Company intelligence / Profile preview
PsyLabs
South Africapsylabs.life ↗
- Ownership
- Public · PBM
- Development stage
- Other
01
Overview
PsyLabs has developed pharmaceutical-grade, nature-derived psilocybin, successfully exported to Canada, UK, Portugal, Slovenia, and supplies clinical and research markets; early-stage results support high-grade APIs, with no independent clinical trial outcomes from PsyLabs reported to date[3][4].
- Therapeutic areas
- Psychiatry
- Modalities
- Small moleculeNatural productExtract
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Psyence Biomed (Clinical trial supply, equity stake, exclusive licensing for API program)[1][2][4]UK-based Contract Manufacturing Organization (CMO, pharma-grade production)[2][4]
Beyond the preview
Go deeper on PsyLabs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PsyLabs.